GSD COVID-19 EIA IgA, IgG, and IgM Kits Have Arrived!
The Gold Standard Diagnostics Group, including Gold Standard Diagnostics Inc, VIROTECH Diagnostics GmbH, and NovaTec Immundiagnostica GmbH, is proud to announce the availability of multiple immunoassays for the separate detection of IgG, IgA, and IgM antibodies to SARS-CoV-2. GSD Followed the FDA’s Emergency Use Notification process as provided in the FDA’s Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency (March 16, 2020). The assays are available for immediate sale in the US.
These assays utilize a SARS-CoV-2 Nucleocapsid recombinant antigen and have been tested against numerous cross-reactive viral species. Several hundred samples have been run on the assay from healthy blood donors, cross-reactive samples, Positive COVID19 patients, and Negative COVID19 patients. The assay workflow is a simple 30:30:30 minute timing scheme at room temperature for ease of use on any open ELISA automation platform.
The Gold Standard Diagnostics Group takes a deliberate approach to assay development to ensure that performance and supply will meet our customer’s expectations.
Sample matrix: Serum
Incubation time: 30min/30min/30min
Incubation Temperature: Room temperature
Antigen: Recombinant Nucleocapsid Protein for excellent sensitivity and
Assay Catalog Number
SARS-CoV-2 IgG GSD01-1028
SARS-CoV-2 IgA GSD01-1029
SARS-CoV-2 IgM GSD01-1030